title: [Screening and intervention. A strategy in type 2 diabetes?].
abstract: Before the introduction of screening for type 2 diabetes, it is necessary to evaluate not only the technology, but also the patient perspective, the economical consequences, and the organising aspects. A review of the relevant literature shows that type 2 diabetes is a rapidly increasing, serious disease. However, there is no documentation that systematic screening will have a positive effect on morbidity and mortality, owing to the lack of randomised clinical trials. The methods for screening could be optimised, and there is a lack of literature on patient perspective. Economical models indicate that opportunistic screening is more cost-effective than is systematic screening, but the lack of randomised trials makes the conclusion dubious. A decision to introduce systematic screening for type 2 diabetes should await the results of ongoing randomised clinical trials. In the meantime, efforts should be spent on improving the level of care for those already diagnosed with diabetes.
authors: Center for Sygdomsforebyggelse, Opgang 8. 7. sal, Amtssygehuset i Glostrup, DK-2600 Glostrup.
authors: Torben
authors: T
authors: Jørgensen
authors: Charlotte
authors: C
authors: Glümer
authors: Knut
authors: K
authors: Borch-Johnsen
mesh_terms: D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003718:Denmark / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D004992:Ethics, Medical; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000458:organization & administration